TekCyte

@TekCyte

World-leading developer and manufacturer of advanced medical coatings.

Mawson Lakes, South Australia tekcyte.com Joined December 2019

35 Following 61 Followers 36 Posts

Latest posts 5

TekCyte @TekCyte Feb 26, 2024

@TekCyte is very excited by Cynata's (@cynatastemcells) interim results. We hope that one day our combined technologies can help reduce the impact of diabetic foot ulcers (DFU) on the quality of life of diabetes sufferers. #diabetes, #chronicwounds, #stemcells

Cynata Therapeutics @cynatastemcells Feb 26, 2024

We have conducted an initial analysis of wound surface area in our Phase 1 clinical trial of CYP-006TK for diabetic foot ulcers, with promising results. Read about it here: cynata.com/cyp-asx-announ… #stemcells #diabetes #ClinicalTrials

View quoted post on X

TekCyte @TekCyte Apr 5, 2023

TekCyte is very excited to be involved in a project with a great team that will help commercialise innovative technologies from @UniversitySA

Dr. Manuela Klingler-Hoffmann @ScienceManu Mar 16, 2023

It truly took a herculean team effort to get this application from idea to submission! I'm so grateful for all the support we (@MumDoesScience, Jason Whittle) have received. THANK YOU! 👏👏👏Fingers crossed 🤞 @UniversitySA @unisaresearch @Flinders @TekCyte #oneteam

View quoted post on X

TekCyte @TekCyte Aug 16, 2022

Great achievement! Congrats to Deborah and her team at Carina.

Carina Biotech @CarinaBiotech Aug 15, 2022

We are extremely pleased to announce that we have raised $7.5 million at first close of our current funding round, welcoming on board new venture capital business Tenmile as the cornerstone investor together with strong support from existing investors.

smh.com.au/business/compa…
View quoted post on X

TekCyte @TekCyte Aug 6, 2022

Well done to the team at Cynata.

Cynata Therapeutics @cynatastemcells Aug 5, 2022

Cynata is excited to announce that we have received a notice of allowance from the United States Patent and Trademark Office. This notice is for the patent application covering the use of MSCs in the treatment of asthma and allergic airways disease.
bit.ly/3yT7uLD
View quoted post on X

TekCyte @TekCyte Jun 17, 2022

It's great to see two technologies coming together to solve a terrible condition that people with diabetes often have to face.

Cynata Therapeutics @cynatastemcells Jun 16, 2022

Cynata’s Cymerus™ mesenchymal stem cells (MSCs) were used in an independent and very successful study conducted by the Cooperative Research Centre for Cell Therapy Manufacturing (CTM CRC) in a preclinical model of diabetic wounds cynata.com/diabetic-wounds

View quoted post on X